These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 25528115)

  • 1. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
    James KD; Forester SC; Lambert JD
    Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenol (-)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway.
    Wang D; Wang Y; Wan X; Yang CS; Zhang J
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):65-74. PubMed ID: 25585349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice.
    James KD; Kennett MJ; Lambert JD
    Food Chem Toxicol; 2018 Jan; 111():302-309. PubMed ID: 29175576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.
    Lambert JD; Kennett MJ; Sang S; Reuhl KR; Ju J; Yang CS
    Food Chem Toxicol; 2010 Jan; 48(1):409-16. PubMed ID: 19883714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
    Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
    Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High doses of (-)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice.
    Cai Y; He SQ; Hong HQ; Cai YP; Zhao L; Zhang M
    Biotechnol Lett; 2015 Dec; 37(12):2371-7. PubMed ID: 26272391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice.
    Church RJ; Gatti DM; Urban TJ; Long N; Yang X; Shi Q; Eaddy JS; Mosedale M; Ballard S; Churchill GA; Navarro V; Watkins PB; Threadgill DW; Harrill AH
    Food Chem Toxicol; 2015 Feb; 76():19-26. PubMed ID: 25446466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
    Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.
    Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
    Lambert JD; Kim DH; Zheng R; Yang CS
    J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenol epigallocatechin-3-gallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.
    Huang J; Li W; Liao W; Hao Q; Tang D; Wang D; Wang Y; Ge G
    Food Funct; 2020 Nov; 11(11):9924-9935. PubMed ID: 33095225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-Gallate Reduces Hepatic Oxidative Stress and Lowers CYP-Mediated Bioactivation and Toxicity of Acetaminophen in Rats.
    Yao HT; Li CC; Chang CH
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of epigallocatechin gallate from green tea on oxidation and tissue incorporation of dietary lipids in mice fed a high-fat diet.
    Friedrich M; Petzke KJ; Raederstorff D; Wolfram S; Klaus S
    Int J Obes (Lond); 2012 May; 36(5):735-43. PubMed ID: 21750518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
    Pandit AP; Joshi SR; Dalal PS; Patole VC
    BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
    Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
    Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary Copper Reduces the Hepatotoxicity of (-)-Epigallocatechin-3-Gallate in Mice.
    Kaleri NA; Sun K; Wang L; Li J; Zhang W; Chen X; Li X
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29295524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts.
    Oketch-Rabah HA; Roe AL; Rider CV; Bonkovsky HL; Giancaspro GI; Navarro V; Paine MF; Betz JM; Marles RJ; Casper S; Gurley B; Jordan SA; He K; Kapoor MP; Rao TP; Sherker AH; Fontana RJ; Rossi S; Vuppalanchi R; Seeff LB; Stolz A; Ahmad J; Koh C; Serrano J; Low Dog T; Ko R
    Toxicol Rep; 2020; 7():386-402. PubMed ID: 32140423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup
    Gu Y; Moroy G; Paul JL; Rebillat AS; Dierssen M; de la Torre R; Cieuta-Walti C; Dairou J; Janel N
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.